Brooks Gabriel 4
4 · Solid Biosciences Inc. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Solid Biosciences CMO Brooks Gabriel Sells 12,616 Shares
What Happened
Brooks Gabriel, Chief Medical Officer of Solid Biosciences (SLDB), disposed of 12,616 shares on 2026-02-04 in an open-market/private sale reported as a sale (S). The transaction was reported at a weighted average price of $6.44 per share for proceeds of approximately $81,271.
Key Details
- Transaction date: 2026-02-04; Form 4 filed 2026-02-06 (filed timely within the 2-business-day window).
- Shares sold: 12,616; weighted average price: $6.44; reported price range: $6.28–$6.60 (sales executed in multiple trades).
- Reason / footnote: Sale was a sell-to-cover to satisfy withholding taxes on vested restricted stock units, per a durable automatic sale instruction letter adopted Aug 15, 2024; not a discretionary trade by Dr. Gabriel (Footnote F1).
- Footnote F2: Reporting person can provide a breakdown of the number of shares sold at each price within the stated range upon request.
- Shares owned after transaction: Not specified in the provided filing.
Context
This was a routine sell-to-cover tax withholding following RSU vesting, which is common and generally not a directional market signal. The filing appears timely.
Insider Transaction Report
Form 4
Brooks Gabriel
Chief Medical Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-02-04$6.44/sh−12,616$81,271→ 84,092 total
Footnotes (2)
- [F1]This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.
Signature
/s/ Kimberly Cornwell as attorney-in-fact for Gabriel Brooks|2026-02-06